ENSURING ACCESSIBILITY TO EXCEPTIONAL CANNABINOIDS
To enhance our portfolio with the highest-quality cannabinoids, we’ve proudly partnered with BayMedica, a subsidiary of InMed Pharmaceuticals. BayMedica is the first cannabinoid supplier to meet our rigorous standards and produce CBC, THCv, and CBDv isolates with vetted and verified excellence.
As manufacturers, we recognize the critical importance of consistent, fully compliant, high-quality input materials and the need to surpass industry standards to deliver exceptional products to our customers. It is with this philosophy and the shared commitment to quality, innovation and customer satisfaction that we proudly announce our authorized distributor partnership of bioidentical cannabinoids, with the scaled-up capacity to meet even the largest industrial application requirements.
BIOIDENTICAL CANNABINOIDS - CONSISTENCY AT SCALE
The explosive growth of non-intoxicating rare and novel cannabinoids, THCV, CBC and CBDV, has necessitated scientific innovation to meet demand. Extracting and refining these cannabinoids from the cannabis sativa plant is both costly and challenging, making it insufficient, let alone scalable, for large-scale commercial applications.
Led by a team of scientists with over 100 years of combined experience, BayMedica is at the forefront of innovative science-based solutions in developing nature-identical functional cannabinoids studied with great interest for their beneficial properties, ranging from mood and energy properties to supporting appetite control for health and wellness. THC-Free and nearly 100% in purity, CBC Isolate, THCV Isolate and CBDV Isolate offers end-product versatility and helps ensure precision formulation ratios and dosing.
English 
Japanese 
Spanish